Antimicrobiology in Epidemiology

Antimicrobial resistance has become a serious healthcare problem, with high resistance rates of most common bacteria to clinically important antimicrobial agents. Resistance has emerged to even the newer, almost potent antimicrobial agents. Methicillin-resistant S. aureus, ESBL-producing Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii represent more than 50% of microbial isolates. Furthermore, bacterial resistance to fluoroquinolones, macrolides and third-generation cephalosporins is of serious concern. The molecular epidemiology and resistance mechanisms of the antimicrobial strains exhibited regional specificity, as well as the influence of dissemination of international clonal complexes.


    Related Conference of Antimicrobiology in Epidemiology

    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France
    December 05-06, 2024

    36th Annual Congress on Vaccine and Clinical Trials

    Vancouver, Canada
    February 27-28, 2025

    8th International Conference on Vaccines and Immunology

    Paris, France
    April 28-29, 2025

    2nd Global Summit on Vaccines & Emerging Diseases

    Bali, Indonesia

    Antimicrobiology in Epidemiology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in